Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Laparoscopic Colorectal Surgery For Cancer- Long Term Survival

The recruitment status of this study is unknown because the information has not been verified recently.
Verified June 2007 by Tel-Aviv Sourasky Medical Center.
Recruitment status was  Not yet recruiting
Sponsor:
Information provided by:
Tel-Aviv Sourasky Medical Center
ClinicalTrials.gov Identifier:
NCT00555295
First received: October 27, 2007
Last updated: November 7, 2007
Last verified: June 2007
  Purpose

The purpose of this study is to determine the survival after laparoscopic colectomies due to carcinoma.


Condition
Colon Cancer

Study Type: Observational
Study Design: Observational Model: Case-Only
Time Perspective: Retrospective
Official Title: Survival After Laparoscopic Colorectal Surgery

Further study details as provided by Tel-Aviv Sourasky Medical Center:

Biospecimen Retention:   Samples Without DNA

Colonic Resection


Estimated Enrollment: 200
Study Start Date: December 2007
Estimated Study Completion Date: February 2008
Detailed Description:

Laparoscopic procedures for Colorectal Carcinoma are taking place in the modern era of surgery, It was not proven yet to show pure advantage over the open colectomies.

These Procedures require highly skilled stuff with long learning curve, Financial sources,Increasing operation length.

This retrospective study intends to show that the outcome of the overall survival is better in Laparoscopic patients.

All data about patients who had laparoscopic colectomies due to carcinoma in Surgery A department in Souraski Medical Center was recorded prospectively since the operation day till discharge.

The retrospective follow up will be collected from the outpatient clinic, the Oncology clinic and by questionnare to the patients.

We wish to show that patients who were operated laparoscopy have better survival, better quality of life postoperatively.

  Eligibility

Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population

Patients with Colon Cancer

Criteria

Inclusion Criteria:

  • Adenocarcinoma of colon

Exclusion Criteria:

  • Non curative operation
  • Non cancerous subjects
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00555295

Contacts
Contact: Smadar Nir +972-524262558

Sponsors and Collaborators
Tel-Aviv Sourasky Medical Center
Investigators
Study Chair: Shmuel Avital, md Tel Aviv Souraski Medical Center
Principal Investigator: Smadar Nir, md Tel Aviv Souraski Medical Center
  More Information

No publications provided

ClinicalTrials.gov Identifier: NCT00555295     History of Changes
Other Study ID Numbers: TASMC-07-AS-389-CTIL
Study First Received: October 27, 2007
Last Updated: November 7, 2007
Health Authority: United States: Food and Drug Administration

ClinicalTrials.gov processed this record on November 19, 2014